Published on
Jan 17, 2025
Dr Nathanson on BRCA1/2 Reversion Mutations in Response to Therapy in Breast Cancer
“We’ve identified 3 new genes in which reversions had not been previously reported. This is particularly important in terms of therapy, as these are not mechanisms of resistance in patients with those underlying mutations. This is the first time that we …
Source:
OncLive
-
Label Pending
.jpeg?width=1200&auto=webp&quality=75&crop=3:2,smart&trim=)
